Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,919 | -6,849 | -5,419 | -3,821 | -1,864 |
| Depreciation Amortization | 50 | 171 | 122 | 90 | 52 |
| Accounts payable and accrued liabilities | 6 | 69 | 16 | -36 | 374 |
| Other Working Capital | 278 | 581 | 661 | 492 | 626 |
| Other Operating Activity | -3 | -26 | 21 | 37 | -373 |
| Operating Cash Flow | $-1,589 | $-6,054 | $-4,599 | $-3,239 | $-1,185 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -174 | N/A | N/A | N/A |
| Investing Cash Flow | $-15 | $-174 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | -4 | -3 | -2 | -1 |
| Common Stock Issued | 125 | 7,094 | 3,847 | 3,847 | N/A |
| Other Financing Activity | 0 | 0 | -465 | -465 | 0 |
| Financing Cash Flow | $124 | $7,090 | $3,379 | $3,380 | $-1 |
| Beginning Cash Position | 5,165 | 4,302 | 4,302 | 4,302 | 4,302 |
| End Cash Position | 3,685 | 5,165 | 3,082 | 4,443 | 3,116 |
| Net Cash Flow | $-1,480 | $863 | $-1,220 | $141 | $-1,186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,589 | -6,054 | -4,599 | -3,239 | -1,185 |
| Capital Expenditure | -19 | -174 | N/A | N/A | N/A |
| Free Cash Flow | -1,608 | -6,227 | -4,599 | -3,239 | -1,185 |